Expanded Use of PAH Medications

This discussion was moderated by Karen A. Fagan, MD, Professor and Director, Division of Pulmonary Medicine, University of South Alabama College of Medicine, Mobile, Alabama. Panel members included Kamal K. Mubarak, MD, Assistant Professor of Medicine, Director, Pulmonary Hypertension Clinic, Wayne State University, Detroit, Michigan; Zeenat Safdar, MD, Assistant Professor of Medicine, Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas; Aaron Waxman, MD, PhD, Associate Professor of Medicine, Harvard Medical School, Director, Pulmonary Vascular Disease Program and Pulmonary Critical Care Unit, Massachusetts General Hospital, Boston, Massachusetts; and Roham T. Zamanian, MD, Assistant Professor of Medicine, Director, Adult Pulmonary Hypertension Clinical Service, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, Stanford, California.

Download Full-text

Protocols in Heart and Lung Transplantation: An Essential Guide to Preoperative Assessment and Timing to Improve Outcomes

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-3.1.20 ◽

2004 ◽

Vol 3 (1) ◽

pp. 20-25

Author(s):

Victor Tapson ◽

Robert Frantz ◽

John Conte

Keyword(s):

North Carolina ◽

Pulmonary Hypertension ◽

Critical Care ◽

Lung Transplantation ◽

Medical Center ◽

Preoperative Assessment ◽

Assistant Professor ◽

Associate Professor ◽

Johns Hopkins University ◽

Duke University

This discussion was moderated by Victor Tapson, MD, Editor-in-Chief of Advances in Pulmonary Hypertension and Associate Professor, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina. The participants included Robert Frantz, MD, Assistant Professor of Medicine, Cardiovascular Division, Mayo Clinic, Rochester, Minnesota; and John Conte, MD, Associate Professor of Surgery and Director of Heart and Lung Transplantation, Johns Hopkins University, Baltimore, MD.

Download Full-text

Meeting the Challenge of Surgery and Pulmonary Hypertension: How to Manage the “Hemodynamic Environment” to Optimize Outcomes

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-6.2.92 ◽

2007 ◽

Vol 6 (2) ◽

pp. 92-95

Author(s):

Richard Channick ◽

Kenneth R. McCurry ◽

Ronald Pearl ◽

Stuart Rich

Keyword(s):

Pulmonary Hypertension ◽

Critical Care ◽

Lung Transplantation ◽

San Diego ◽

Medical Center ◽

Assistant Professor ◽

Associate Professor ◽

University Of California ◽

University Of Pittsburgh ◽

School Of Medicine

This discussion was moderated by Richard Chan-nick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California. Panel members included Kenneth R. McCurry, MD, Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Director, Lung and Heart-Lung Transplantation Programs, University of Pittsburgh Department of Surgery, Pittsburgh, Pennsylvania; Ronald Pearl, MD, PhD, Professor and Chair, Anesthesia Department, Stanford University School of Medicine, Stanford, California; and Stuart Rich, MD, Professor of Medicine, Section of Cardiology, Center for Pulmonary Hypertension, University of Chicago, Chicago, Illinois.

Download Full-text

Pulmonary Hypertension Roundtable: Perspectives on PHA's 10th International PH Conference

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-11.3.135 ◽

2012 ◽

Vol 11 (3) ◽

pp. 135-140

Keyword(s):

Pulmonary Hypertension ◽

Medical Center ◽

Assistant Professor ◽

Associate Professor ◽

Medical Director ◽

Pulmonary Vascular Disease ◽

University Of Utah ◽

University Of Colorado ◽

Assistant Director ◽

Vanderbilt University

As a way to integrate the presentations at PHA's June scientific sessions with clinical practice, Guest Editor Karen Fagan, MD, convened a group of attendees to discuss their experience in Orlando. The discussants included Todd Bull, MD, Associate Professor, Medical Director, Anschutz Intensive Care Unit, University of Colorado, Aurora, Colorado; Anna Hemnes, MD, Assistant Director, Center for Adult Pulmonary Vascular Disease, Vanderbilt University, Nashville, Tennessee; C. Gregory Elliott, MD, Professor of Medicine, University of Utah and Medical Director, Pulmonary Hypertension Center, Intermountain Medical Center, Murray, Utah; Vinicio A. de Jesus Perez, MD, Assistant Professor in Medicine and Staff Physician, Wall Center Adult PH Clinic, Stanford University Medical Center, Palo Alto, California; and Paul B. Yu, MD, PhD, Brigham and Women's Hospital, Boston, Massachusetts.

Download Full-text

Sickle Cell Disease and Pulmonary Hypertension: Addressing the Mixed Pathology and Special Considerations in Diagnosis and Treatment

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-6.1.39 ◽

2007 ◽

Vol 6 (1) ◽

pp. 39-44

Author(s):

Harrison W. Farber ◽

Mark Gladwin ◽

Evelyn M. Horn ◽

Myung H. Park

Keyword(s):

New York ◽

Pulmonary Hypertension ◽

Vascular Disease ◽

Clinical Medicine ◽

Medical Center ◽

Associate Professor ◽

Pulmonary Vascular Disease ◽

Vascular Medicine ◽

Blood Institute ◽

School Of Medicine

This discussion was moderated by Evelyn M. Horn, MD, Associate Professor of Clinical Medicine and Director, Pulmonary Vascular Disease, Center for Advanced Cardiac Care, Columbia University Medical Center, New York, New York. Panel members included Harrison W. Farber, MD, Director, Pulmonary Hypertension Center, Boston Medical Center, Boston University School of Medicine; Mark Gladwin, MD, Chief, Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD; Myung H. Park, MD, Director, Pulmonary Vascular Disease Program, University of Maryland School of Medicine.

Download Full-text

Pulmonary Hypertension Roundtable

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-4.2.24 ◽

2005 ◽

Vol 4 (2) ◽

pp. 24-29

Author(s):

Richard Channick ◽

Hap Farber ◽

Nicholas Hill ◽

Robert Schilz

Keyword(s):

Pulmonary Hypertension ◽

Critical Care ◽

New England ◽

San Diego ◽

Medical Center ◽

Assistant Professor ◽

Associate Professor ◽

University Of California ◽

Boston University ◽

England Medical

This discussion was moderated by Richard Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California. The physicians participating included Hap Farber, MD, Director, Pulmonary Hypertension Center, Boston University Medical Center, Boston, Massachusetts; Nicholas Hill, MD, Chief, Pulmonary, Critical Care and Sleep Division, Tufts-New England Medical Center, Boston, Massachusetts; and Robert Schilz, PhD, DO, Director of Lung Transplantation and Advanced Lung Disease, and Assistant Professor of Medicine, Case Western Reserve University, Cleveland, Ohio.

Download Full-text

Pulmonary Hypertension Roundtable: The Present and Future of Imaging in Pulmonary Hypertension

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-18.4.134 ◽

2019 ◽

Vol 18 (4) ◽

pp. 134-140

Keyword(s):

Pulmonary Hypertension ◽

Right Heart Failure ◽

Assistant Professor ◽

Associate Professor ◽

Pulmonary Vascular Disease ◽

University Of Washington ◽

Temple University ◽

School Of Medicine ◽

Johns Hopkins University ◽

The University

This fall, Guest Editors Jeffrey D. Edelman, MD, Associate Professor of Medicine at the University of Washington in Seattle, and Harrison W. Farber, MD, Professor of Medicine at Tufts University School of Medicine in Boston, Massachusetts, convened a panel of experts to discuss the role of imaging in pulmonary hypertension. Guests included Benjamin H. Freed, MD, Assistant Professor of Medicine at Northwestern University Feinberg School of Medicine in Chicago, Illinois; Paul Hassoun, MD, Director of the Pulmonary Hypertension Program and Professor of Medicine at Johns Hopkins University Department of Medicine in Baltimore, Maryland; Peter Leary, MD, PhD, Associate Professor of Medicine and Director of the Pulmonary Vascular Disease Program at the University of Washington in Seattle; Sudhakar N.J. Pipavath, MD, Professor of Cardiothoracic Imaging and Adjunct Professor of Pulmonary, Critical Care, Sleep Medicine and Medicine at the University of Washington in Seattle; and Anjali Vaidya, MD, FACC, FASE, FACP, Associate Professor of Medicine and Co-Director, Pulmonary Hypertension, Right Heart Failure and CTEPH Program at Temple University in Philadelphia, Pennsylvania.

Download Full-text

Roundtable Discussion of the Impact of the 4th World Symposium on Pulmonary Hypertension

Advances in Pulmonary Hypertension ◽

10.21693/1933-088x-8.2.89 ◽

2009 ◽

Vol 8 (2) ◽

pp. 89-94

Author(s):

Robyn J. Barst ◽

Marc Humbert ◽

Ivan M. Robbins ◽

Lewis J. Rubin ◽

Robyn J. Park

Keyword(s):

New York ◽

Pulmonary Hypertension ◽

Vascular Diseases ◽

Assistant Professor ◽

Associate Professor ◽

Future Research ◽

Columbia University ◽

School Of Medicine ◽

Maryland School ◽

The Impact

A discussion among attendees of the 4th World Symposium on Pulmonary Hypertension took place to share “an insider's look” into the current and future research and treatment implications in pulmonary hypertension. Myung H. Park, MD, guest editor of this issue of Advances in Pulmonary Hypertension, Assistant Professor of Medicine and Director, Pulmonary Vascular Diseases Program, Division of Cardiology, University of Maryland School of Medicine, Baltimore, moderated the discussion. Participants included Robyn Barst, MD, Professor Emerita, Columbia University, New York; Marc Humbert, MD, PhD, Universite Paris-Sud, French Referal Center for Pulmonary Hypertension, Hopital Antoine-Beclere, Assistance Publique Hopitaux de Paris, Clamart, France; Ivan Robbins, MD, Associate Professor of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; and Lewis J. Rubin, MD, Clinical Professor, Department of Medicine, University of California, San Diego.

Download Full-text